This interview by our Associate Medical Director, Dr. Victor Rodriguez Freixinos, provides an overview about Glioblastoma, an extremely aggressive yet very common brain cancer. The interview is divided as follows:
0:14 What is Glioblastoma?
0:38 How many people are affected by glioblastoma annually?
1:02 What are the main treatment challenges of glioblastoma?
2:23 Could ongoing research benefit patients in the future?
Enjoy the clip!
For more information on Debiopharm’s ongoing fight against glioblastoma, visit https://www.debiopharm.com/drug-development/press-releases/debiopharm-launches-phase-1-2-combination-trial-investigating-brain-penetrant-selective-wee1-inhibitor-for-brain-cancer-patients/